Skip to main content
Premium Trial:

Request an Annual Quote

David Thorpe, John Clouston, Leonard Keenan

David Thorpe, John Clouston, and Leonard Keenan have joined Ariadne’s North American and European sales teams, Ariadne Genomics said this week.
 
Clouston joins Ariadne as sales manager in the North American market. Previously, he held a similar position at Silicon Genetics (now GeneSpring at Agilent Technologies). 
 
Thorpe has been appointed director of enterprise sales and will lead corporate and enterprise sales efforts in North America and Europe. He held senior-level positions at OriGene Technologies, CambridgeSoft, and InforMax (now Invitrogen).
 

Keenan serves as business development associate for the European market. He previously held business development and sales management positions at a variety of software companies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.